Document Detail

BAS/BSCR3 Partial reconstruction of myocardial metabolic pathways following analysis of peripheral serum using metabolomics in early cardiac ischaemia.
MedLine Citation:
PMID:  20801796     Owner:  NLM     Status:  In-Data-Review    
Cardiac metabolism and cardiac function are inextricably linked, with changes in cardiac metabolism during cardiac ischaemia contributing to the development of cardiac arrhythmias. Using metabolomics, we aim to identify metabolite changes occurring during cardiac ischaemia through analysis of peripheral serum to reconstruct myocardial metabolic pathways that contribute to the development of cardiac arrhythmias. Peripheral venous samples from 25 patients (and 20 patients in a validation cohort) were analysed in an untargeted fashion using LC-MS following cardiac ischaemia induced by transient coronary artery occlusion during PCI at baseline, 1 and 5 min. Following validation, 99 and 126 metabolite peaks were significantly different at 1 min and 5 min after coronary occlusion compared with baseline (p<0.05). Predominantly metabolic pathways involving lipids were perturbed with changes in diacylglycerols (DG), lysophophatidylcholines (LPC), phosphatidylcholine (PC) and free fatty acids (FFA). Myocardial metabolic pathways involving the synthesis of PC from DG and their subsequent breakdown by phospholipase A2 into LPC and FFA such as arachidonic acid (AA) stimulating the oxidation of adrenaline to form the arrhythmogenic metabolite adrenochrome were reconstructed. We are able to reconstruct metabolic pathways involving lipid metabolism within the myocardium during cardiac ischaemia through analysis of the peripheral serum using metabolomics. Our unbiased approach has identified metabolic pathways involved in the production and release of metabolites with pro-arrhythmic properties (AA, LPC and adrenochrome) and metabolites with anti-arrhythmic properties (omega-3 fatty acids: eicosapentaenoic and docosahexanoic acid). This suggests that arrhythmogenesis may be a delicate balance between the endogenous formation of pro-arrhythmic and anti-arrhythmic metabolites.
M A Mamas; W B Dunn; D Broadhurst; S Chacko; M Brown; M El-Omar; F Fath-Ordoubadi; R Goodacre; D B Kell; L Neyses
Related Documents :
6853736 - Serum malondialdehyde-like material (mda-lm) in acute myocardial infarction.
16568436 - Multislice multiecho t2* cardiovascular magnetic resonance for detection of the heterog...
8472386 - Trace element concentrations (cu, zn, fe) in sera from patients with dilated cardiomyop...
10643986 - Anthracycline cardiotoxicity in a black rhinoceros (diceros bicornis): evidence for imp...
24970296 - Impact of red blood cell distribution width on long-term mortality in patients with st-...
18250366 - Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ische...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Heart (British Cardiac Society)     Volume:  96     ISSN:  1468-201X     ISO Abbreviation:  Heart     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602087     Medline TA:  Heart     Country:  England    
Other Details:
Languages:  eng     Pagination:  e13     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  BAS/BSCR4 The role of receptor activator of nuclear factor {kappa}-B ligand and its decoy receptor, ...
Next Document:  BAS/BSCR8 Does macrophage foam cell formation promote extracellular matrix formation or degradation?...